Physician profile
Daniel Gardner Lustig
NPI 1952458747
$295.34
in general payments reported to CMS, 2019-2025
9 companies · $71.92 in 2025
The $71.92 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.72 · 2020: $40.55 · 2022: $20.11 · 2023: $59.61 · 2024: $49.43 · 2025: $71.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145 · Education: $35.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.04 |
| Education | $35.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $153.02 | 2023-2025 | Dupixent |
| Sarepta Therapeutics, INC. | $28.30 | 2019 | |
| Sunovion Pharmaceuticals INC. | $25.98 | 2019-2020 | |
| Novo Nordisk INC | $20.11 | 2022 | |
| Greenwich Biosciences, INC. | $15.43 | 2020 | |
| Ascendis Pharma Endocrinology INC | $14.18 | 2025 | Skytrofa |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2024 | Eohilia |
| Insulet Corporation | $12.31 | 2019 | |
| Abbvie INC. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lustig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.